Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Rebranding Issue.

Rebranding Issue.

posted on Oct 24, 2008 11:48AM

The idea of rebranding PTSC is worth looking into IMO. The reality is most of the investor/institutions that Mr. Goerner will speak with are already aware of the Patriot story. We know damn well that the conferences, he has and will be attending, are frequented by many of the same investors. I'm sure many of them have seen Mr. Pohl, Mr. Turely and now Mr. Goerner. The only difference, IMO, is a new talking head for PTSC delivering the message that has otherwise produced only a few tangible results. I do feel like the "Interim" title should be removed. Mr. G will undoubtedly come across persons who know the story but chuckle because another "new" CEO from Patriot is pushing the story. Not only that but, the company hasn't even endorsed him will full time employment.

Perhaps a company name change more reflective of our new direction would be in order. At this point and time what could it hurt? I do believe our name is perceived to be mostly negative in terms of delivery on shareholder value. Let Mr. Goerner and company repackage and rebrand our company giving us a fresh start. I know it won't solve the current situation but it certainly may be another piece in the puzzle to "starting a new" as they say.

Share
New Message
Please login to post a reply